Tag Archives: health

Kenneth Thorpe: America Subsidizes Medical Innovation for World

Test Tubes

Kenneth Thorpe, chairman of the Partnership to Fight Chronic Disease and a former deputy assistant secretary for Health Policy at HHS, wrote a post for The Hill this week pointing out what is left unstated in many current discussions about the price of innovative medicines and treatments: other nations aren’t paying their fair share for medical advancements, driving up the costs here at home: Patients throughout the globe benefit from the pharmaceuticals, medical devices and Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , ,

Center for Medicine in the Public Interest Challenges Accuracy of 60 Minutes Cancer Story

scientist-eyedropper

This week, the Center for Medicine in the Public Interest issued a press release criticizing CBS’ “60 Minutes” segment on cancer treatment prices as not just distorted but ‘dead wrong.’ “Featuring physicians that argue that treatment prices are too high does not change the fact that the cost of cancer drugs are about 12 percent of what health insurers spend on cancer or that new cancer drugs actually save health insurers money. Yet insurers are Read More >

Health, Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Tekmira CEO Discusses Ebola Therapy Development at 2014 BIO Investor Forum

Tekmira CEO

Today at the 13th Annual BIO Investor Forum, Tekmira CEO Dr. Mark Murray participated in a conversation with Phyllis Arthur, BIO’s Senior Director for Vaccines, Immunotherapeutics, and Diagnostics Policy. Tekmira has been in the spotlight recently due to their experimental Ebola therapy, TKM-Ebola. Recently, they announced that FDA has allowed them to provide TKM-Ebola for treatment under expanded access protocols, and that they have joined an international consortium to conduct clinical trials of Ebola virus therapeutics Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

T-Cell Therapies: Best Bets in Pushing Down the Cost Curve and Prioritizing Cancer Targets

BIO Investor Forum

New approaches in cancer immunology are achieving promising early-stage results through novel techniques for arming the body’s own t-cells to have greater impact on reducing tumors and preventing the spread of disease. CAR-T methods that extract, reengineer, and reintroduce a given patient’s t-cells provide highly personalized therapy but may be difficult to scale up. The interleukin enhancement approach motivates existing t-cells to be more effective and may be easier to deliver but have less pervasive Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Gates Foundation and Grand Challenge Partners Announce New Investments in Breakthrough Science

Vaccination

At an event in Seattle today, the Bill & Melinda Gates Foundation and a group of international partners announced three new initiatives aimed at encouraging breakthroughs in science. The event celebrates a decade of progress since the Gates Foundation’s launch of the initial Grand Challenges in Global Health initiative, which was created to catalyze scientific and technological innovation to achieve major breakthroughs in global health. The three new initiatives include: • All Children Thriving – Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , ,